Solventum Financial Statements
NYSE: SOLVHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Solventum revenue and earnings
In fiscal 2025, Solventum generated $8.32 billion in revenue, up 0.9% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $1.56 billion (+224.8% year over year), for a net margin of 18.7% versus a median of 16.4% in the prior 3 years. Gross margin was 53.5% (down from 55.6%) and operating margin 26.2%.
Diluted earnings per share came in at $8.88, up from $2.76. Over the last 3 fiscal years, SOLV's revenue has grown at a 0.8% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Solventum income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 |
|---|---|---|---|---|
| Revenue | 8.32B | 8.25B | 8.20B | 8.13B |
| Revenue growth (YoY) | +0.86% | +0.70% | +0.82% | — |
| Gross Profit | 4.45B | 4.59B | 4.69B | 4.70B |
| Operating Expenses | 2.27B | 3.56B | 3.00B | 3.00B |
| Research & Development | 739.00M | 775.00M | 758.00M | 767.00M |
| Selling, General & Admin | 3.08B | 2.78B | 2.30B | 2.23B |
| Operating Income | 2.18B | 1.04B | 1.69B | 1.69B |
| Other Income (Expense) | -39.00M | -64.00M | -25.00M | -1.00M |
| Pretax Income | 1.71B | 605.00M | 1.67B | 1.69B |
| Income Tax | 157.00M | 127.00M | 321.00M | 349.00M |
| Net Income | 1.56B | 479.00M | 1.35B | 1.34B |
| Net Income growth (YoY) | +224.84% | -64.41% | +0.22% | — |
| EPS (Basic) | 8.94 | 2.77 | 7.79 | 7.78 |
| EPS (Diluted) | 8.88 | 2.76 | 7.79 | 7.78 |
| Shares Outstanding (Basic) | 174.10M | 173.20M | 172.70M | 172.70M |
| Shares Outstanding (Diluted) | 175.30M | 173.70M | 172.70M | 172.70M |
| EBITDA | 2.67B | 1.59B | 2.25B | 2.27B |
| Gross Margin | 53.47% | 55.65% | 57.25% | 57.75% |
| Operating Margin | 26.20% | 12.55% | 20.64% | 20.82% |
| Net Margin | 18.69% | 5.80% | 16.42% | 16.52% |
This table shows 4 annual periods of Solventum's income statement, from FY 2025 back to FY 2022, across 18 line items including revenue, gross profit, operating expenses. Values in USD; B = billions, M = millions. Fiscal periods follow SOLV's reporting calendar. What is a income statement?